Skip to content

A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women

A Comparison of Farabloc Fabric With Placebo on Alleviation Hot Flash in Menopausal Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02006238
Acronym
Flash
Enrollment
50
Registered
2013-12-10
Start date
2014-02-28
Completion date
2014-12-31
Last updated
2014-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause

Keywords

Hot flash, Farabloc, menopausal women

Brief summary

This is a prospective, randomized, double-blind, crossover study. The purpose of this study is to determine whether Farabloc fabric is effective in alleviation of hot flash symptoms in menopausal women. This study will require all prospective participants to fill out a week of Hot Flash Diary to determine eligibility before beginning the study. All prospective participants will be assessed for hot flash frequency, hot flash distress and hot flash severity according to their perception in the Hot Flash Diary during the experimental period.

Detailed description

Fifty menopausal volunteers will be randomly assigned to two groups, one receiving Farabloc fabric containing Farabloc (experimental), and the other a similar-appearing fabric made of Nylon (placebo). All eligible participants will be selected by the initial interview. The following information will be collected during interview process. * Address * Medical history * Concomitant medication * Allergies Participants will be asked the following: 1. On a scale from 1 to 10, how much are you bothered by your hot flashes? 2. Do these hot flashes wake you up at night? Around how many times do they occur at night? 3. What are you expectations about this study? A Menopause Rating Scale questionnaire will be completed by the potential participant to assess symptoms Eligible patients from each group will initially undergo a 7 day washout period before intervention in order to eliminate any effects of hormone replacement therapies (HRT) or herbal supplements that subjects may be using prior to participation in the study. Subjects will be randomized to receive a Farabloc fabric or placebo fabric for one week. After this, the two groups will undergo a second 7 day washout period before crossing over to the other fabric. Once crossed over, participants will use the allocated fabrics for another week. Participants will be asked not to take their usual HRT or herbal supplements for the entire experimental duration in this study in order to produce impartial, precise and reliable results. The manufacturer will assign codes for placebo fabric or experimental Farabloc. The randomization code will be broken at the completion of the study for data analysis.

Interventions

DEVICEFarabloc

The participants will be randomly received Farabloc (experimental) for one week, followed by a 7 day washout and then crossed over to received the Nylon fabric (placebo) for one week.

DEVICENylon Fabric

The participants will be randomly received Nylon fabric (placebo) for one week, followed by a 7 day washout and then crossed over to receive Farabloc (experimental) for one week.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Women with 12 months amenorrhea * Experiencing more than 2 nocturnal hot flashes nightly.

Exclusion criteria

* Other medical conditions associated with night sweats * Currently on medication associated with night sweats * Less than 2 nocturnal hot flashes per night * Allergies to metals * Abnormal mental status * MRS scale rating of mild or above * Currently on hormone replacement therapy or herbal supplements and cannot safety discontinue these for the duration of the study.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of hot flashesin the past 24 hoursThe number of hot flashes subjects experienced in the past 24 hours

Secondary

MeasureTime frameDescription
Severity of hot flashIn the past 24 hoursAn overall severity rating of hot flashes using a 10 point numeric scale 0 (not at all ) to 10 (extremely)

Countries

Canada

Contacts

Primary ContactYork N Hsiang, MB FRCSC
york.hsiang@vch.ca604.876.5882
Backup ContactRollin Y Yu
rollinyu@hotmail.com778.321.7921

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026